Fund Holdings — BML Capital Management, LLC

Total Portfolio Value:
$126.65M
Total Bought:
$58.88M
Total Sold:
$35.28M
Net Transaction:
+$23.60M
Securities
▲▼
SharesValue
Q3 2023
▲▼
Q4 2023
▲▼
Change
▲▼
Q3 2023
▲▼
Q4 2023
▲▼
Weight (%)
▲▼
Change
▲▼
Ishares Tr0 3 MNTH TREASRY
0-3 MTH TREASURY
0270,000+270,000$0$27.07M21.38%+$27.07M
Spdr Ser TrBLOOMBERG 1 3 MO
ST STR BLO 1 ETF
200,000200,0000$18.36M$18.28M14.43%-$86.0K
Atea Pharmaceuticals, Inc.(AVIR)4,800,0005,462,079+662,079$14.40M$16.66M13.15%+$2.26M
Cyteir Therapeutics Inc3,250,0083,250,0080$9.23M$9.88M7.80%+$650.0K
Tourmaline Bio Inc0245,500+245,500$0$6.43M5.07%+$6.43M
Climb Bio, Inc.(CLYM)1,938,2632,180,000+241,737$5.10M$5.89M4.65%+$788.4K
Avrobio Inc4,001,6274,001,6270$6.16M$5.44M4.30%-$720.3K
Theseus Pharmaceuticals Inc01,108,320+1,108,320$0$4.49M3.54%+$4.49M
Athira Pharma Inc1,704,3621,454,362-250,000$3.44M$3.53M2.79%+$91.3K
Adverum Biotechnologies Inc3,915,0004,554,252+639,252$5.87M$3.43M2.71%-$2.44M
Oramed Pharmaceuticals Inc.(ORMP)781,2921,261,559+480,267$2.04M$2.91M2.30%+$875.0K
Design Therapeutics, Inc.(DSGN)01,029,478+1,029,478$0$2.73M2.15%+$2.73M
Connect Biopharma Hldgs LtdADS02,061,438+2,061,438$0$2.43M1.92%+$2.43M
Reneo Pharmaceuticals Inc01,314,229+1,314,229$0$2.10M1.66%+$2.10M
Astrotech Corp220,410220,4100$2.23M$1.87M1.48%-$354.9K
Rain Oncology Inc72,9261,349,007+1,276,081$62.8K$1.62M1.28%+$1.56M
Forte Biosciences Inc1,761,7021,761,7020$1.17M$1.45M1.14%+$281.3K
Verrica Pharmaceuticals Inc.(VRCA)150,000180,000+30,000$582.8K$1.32M1.04%+$734.9K
Arca Biopharma Inc706,930706,9300$1.42M$1.20M0.95%-$219.1K
Graphite Bio Inc0447,416+447,416$0$1.17M0.93%+$1.17M
Kinnate Biopharma Inc0468,210+468,210$0$1.11M0.88%+$1.11M
Vistagen Therapeutics, Inc.(VTGN)100,000150,000+50,000$524.0K$771.0K0.61%+$247.0K
Milestone Pharmaceuticals Inc.(MIST)272,500442,352+169,852$844.8K$738.7K0.58%-$106.0K
Lisata Therapeutics, Inc.(LSTA)243,839269,839+26,000$521.8K$736.7K0.58%+$214.8K
Enliven Therapeutics Inc50,00050,0000$683.0K$692.0K0.55%+$9.0K
Aclaris Therapeutics, Inc.(ACRS)0653,107+653,107$0$685.8K0.54%+$685.8K
Neurogene Inc.(NGNE)024,666+24,666$0$478.0K0.38%+$478.0K
Homology Medicines Inc0748,108+748,108$0$454.9K0.36%+$454.9K
CalciMedica, Inc.(CALC)88,781145,424+56,643$236.1K$415.9K0.33%+$179.8K
Nextcure Inc306,465306,4650$395.3K$349.4K0.28%-$46.0K
Talis Biomedical Corp042,743+42,743$0$318.4K0.25%+$318.4K
ISHARES TR0-3 MNTH TREASRY270,0000-270,000$27.18M$0—-$27.18M
NEOLEUKIN THERAPEUTICS INCCOM NEW98,6640-98,664$389.7K$0—-$389.7K
PASSAGE BIO INCCOM(PASG)2,058,7670-2,058,767$1.35M$0—-$1.35M
RETRACTABLE TECHNOLOGIES INCCOM(RVP)499,9590-499,959$595.0K$0—-$595.0K
SURROZEN INCCOM(SRZN)89,2710-89,271$43.7K$0—-$43.7K
TALARIS THERAPEUTICS INCCOM2,000,0000-2,000,000$5.62M$0—-$5.62M
Page 1 of 1
BML Capital Management, LLC — 13F Holdings — Q4 2023 | TickerTrail